Nathalie Sordello Wagner

Title: Nathalie Sordello Wagner: Innovator in Dermatological Treatments

Introduction

Nathalie Sordello Wagner is a prominent inventor based in Pegomas, France. She has made significant contributions to the field of dermatology, particularly in the treatment of rosacea. With a total of 2 patents, her work focuses on innovative therapies that improve patient outcomes.

Latest Patents

Wagner's latest patents include groundbreaking methods for treating inflammatory lesions of rosacea with ivermectin. The first patent describes methods for safe and effective treatment, which involve once-daily topical application of a composition containing ivermectin and a pharmaceutically acceptable carrier. This method has been shown to be significantly more effective than the conventional twice-daily treatment with metronidazole in reducing inflammatory lesion counts. The second patent addresses the treatment of papulopustular rosacea, also utilizing ivermectin. This innovative therapy offers a more robust and effective alternative to traditional treatments.

Career Highlights

Wagner is associated with Galderma S.A., a company known for its commitment to dermatological research and development. Her work has not only advanced treatment options for rosacea but has also contributed to the broader field of dermatology.

Collaborations

Wagner collaborates with notable colleagues, including Jean Jacovella and Jean-Paul Chappuis. These partnerships enhance her research and development efforts, leading to more effective treatments.

Conclusion

Nathalie Sordello Wagner is a trailblazer in the field of dermatology, with her innovative patents paving the way for improved treatments for rosacea. Her contributions are vital in enhancing patient care and advancing medical science.